Isolation of mutant cells lacking Insig-1 through selection with SR-12813, an agent that stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

被引:49
作者
Sever, N [1 ]
Lee, PCW [1 ]
Song, BL [1 ]
Rawson, RB [1 ]
DeBose-Boyd, RA [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA
关键词
D O I
10.1074/jbc.M406406200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insig-1 and Insig-2 are membrane proteins of the endoplasmic reticulum that regulate lipid metabolism by the following two actions: 1) sterol-induced binding to 3-hydroxy-3-methylglutaryl-coenzyme A reductase, an action that leads to ubiquitination and degradation of the enzyme; and 2) sterol-induced binding to SREBP cleavage-activating protein, an action that blocks the proteolytic processing of sterol regulatory element-binding proteins (SREBPs), membrane-bound transcription factors that enhance the synthesis of cholesterol and fatty acids. Here we report the isolation of a new mutant line of Chinese hamster ovary cells, designated SRD-14, in which Insig-1 mRNA and protein are not produced due to a partial deletion of the INSIG-1 gene. The SRD-14 cells were produced by gamma-irradiation, followed by selection with the 1,1-bisphosphonate ester SR-12813, which mimics sterols in accelerating reductase degradation but does not block SREBP processing. SRD-14 cells fail to respond to sterols by promoting reductase ubiquitination and degradation. The rate at which sterols suppress SREBP processing is significantly slower in SRD-14 cells than wild type CHO-7 cells. Sterol regulation of reductase degradation and SREBP processing is restored when SRD-14 cells are transfected with expression plasmids encoding either Insig-1 or Insig-2. These results provide formal genetic proof for the essential role of Insig-1 in feedback control of lipid synthesis in cultured cells.
引用
收藏
页码:43136 / 43147
页数:12
相关论文
共 49 条
[1]   HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins [J].
Bays, NW ;
Wilhovsky, SK ;
Goradia, A ;
Hodgkiss-Harlow, K ;
Hampton, RY .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (12) :4114-4128
[2]   Cdc48-Ufd1-NpI4: Stuck in the middle with Ub [J].
Bays, NW ;
Hampton, RY .
CURRENT BIOLOGY, 2002, 12 (10) :R366-+
[3]   The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase [J].
Berkhout, TA ;
Simon, HM ;
Patel, DD ;
Bentzen, C ;
Niesor, E ;
Jackson, B ;
Suckling, KE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14376-14382
[4]   SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis [J].
Berkhout, TA ;
Simon, HM ;
Jackson, B ;
Yates, J ;
Pearce, N ;
Groot, PHE ;
Bentzen, C ;
Niesor, E ;
Kerns, WD ;
Suckling, KE .
ATHEROSCLEROSIS, 1997, 133 (02) :203-212
[5]   The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor [J].
Brown, MS ;
Goldstein, JL .
CELL, 1997, 89 (03) :331-340
[6]   A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood [J].
Brown, MS ;
Goldstein, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11041-11048
[7]  
BROWN MS, 1978, J BIOL CHEM, V253, P1121
[8]  
BROWN MS, 1980, J LIPID RES, V21, P505
[9]  
DAWSON PA, 1991, J BIOL CHEM, V266, P9128
[10]   Transport-dependent proteolysis of SREBP: Relocation of Site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi [J].
DeBose-Boyd, RA ;
Brown, MS ;
Li, WP ;
Nohturfft, A ;
Goldstein, JL ;
Espenshade, PJ .
CELL, 1999, 99 (07) :703-712